Banco Bradesco's second quarter delivered the tenth consecutive quarter of rising recurring net income, a milestone few emerging-market banks can match, and the result landed inside the framing the company itself set out: revenues held up against a high-rate Brazilian macro, expenses stayed below inflation, the loan book grew double digits, and credit quality moved only marginally. Recurring net income reached R$7.05 billion (~$1.36 billion) in 2Q26, up 16.2% year over year and 3.5% sequentially, lifting 1H26 recurring net income to R$13.86 billion (~$2.68 billion) versus R$11.93 billion (~$2.30 billion) a year earlier, a 16.2% increase. The growth was driven by client net interest income (+13.8% year over year), a 14.1% advance in the insurance business over the half, and a 3.4-point improvement in the operating efficiency ratio to 46.5% - each component a different lever, all pulling in the same direction.
The more consequential item in the quarter was not in the income statement. After quarter-end, Bradesco's Board approved a capital increase of up to R$10 billion (~$1.93 billion) to bolster the Common Equity Tier 1 ratio to 13.6% pro forma (from 11.3% at quarter-end and 10.2% three months earlier), with controlling shareholders committing a minimum R$8 billion (~80% of the total) and an advance payment of R$6.5 billion (~$1.26 billion) in Interest on Shareholders' Equity (JCP) for September 15, 2026 to enable subscription. This is a real-earnings story that the market is now reading through a capital-allocation lens: recurring ROAE expanded to 16.2% in 2Q26 (versus 14.7% in 2Q25), insurance net income grew 28.3% in the quarter, and the loan book grew 11.6% in twelve months - all while the CET1 ratio improved 110 basis points sequentially. The open question is whether the R$10 billion capital raise can land without crushing the existing shareholders' book value per share, and the falsifiable signal is the subscription price relative to the R$17.15 book value per share at June 30.